[ET Net News Agency, 29 July 2021] Kangji Medical Holdings Limited (09997) said for the
six months ended 30 June 2021, the group is expected to record an increase of more than
49% in revenue and an increase of more than 140% in net profit attributable to owners of
the parent, in each case, as compared to the corresponding period in 2020.
The expected increase in revenue was primarily attributable to (i) the significant
recovery in elective surgery volume in China after the containment of COVID-19 pandemic,
resulting in the increase in demand for the group's products; (ii) expansion and
optimization of distributor network driving the expansion and penetration of end markets
across product portfolio; and (iii) contribution of sales from new products.
The expected increase in net profit attributable to owners of the parent for was mainly
due to the increase in revenue, increase in other income (e.g. bank interest income), the
absence of listing expenses and non-controlling interest, and reduction of share-based
payment expenses. (RC)
|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09997 KANGJI MEDICAL
Nominal 
6.550 -0.210 (-3.107%) Others
29/07/2021 14:08
Kangji Medical (09997) sees 140% increase in interim net
| Remark: | Real time quote last updated: 19/04/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service |